 randomized trial ticarcillin clavulanate versus gentamicin clindamycin patients complicated appendicitis Secondary bacterial peritonitis polymicrobial infection facultative gram-negative aerobic anaerobic organisms Treatment operation broad-spectrum antibiotic administration antibiotic treatment choice infections combination gentamicin clindamycin combination toxic side effects necessitates frequent monitoring serum levels Beta-lactam antibiotics broad-spectrum coverage low toxicity species bacteria beta-lactamase enzymes Clavulanic acid potent inhibitor beta-lactamases efficacy ticarcillin enzymes combination gentamicin clindamycin consecutive patients complicated appendicitis Eradication identified pathogens ticarcillin clavulanate group cent gentamicin clindamycin group cent subgroup organisms beta-lactamases versus cent eradication Complications clinical response different treatment groups Ticarcillin clavulanic acid safe effective alternative treatment secondary bacterial peritonitis advantages simplicity freedom ototoxic nephrotoxic effects